首页 > 最新文献

Medical Care最新文献

英文 中文
Clinical Outcomes Among High-Risk Primary Care Patients With Diabetic Kidney Disease: Methodological Challenges and Results From the STOP-DKD Study. 糖尿病肾病高危初级保健患者的临床疗效:方法学挑战与 STOP-DKD 研究结果。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-07-18 DOI: 10.1097/MLR.0000000000002043
Hayden B Bosworth, Uptal D Patel, Allison A Lewinski, Clemontina A Davenport, Jane Pendergast, Megan Oakes, Matthew J Crowley, Leah L Zullig, Sejal Patel, Jivan Moaddeb, Julie Miller, Shauna Malone, Huiman Barnhart, Clarissa J Diamantidis

Background/objective: Slowing the progression of diabetic kidney disease (DKD) is critical. We conducted a randomized controlled trial to target risk factors for DKD progression.

Methods: We evaluated the effect of a pharmacist-led intervention focused on supporting healthy behaviors, medication management, and self-monitoring on decline in estimated glomerular filtration rate (eGFR) for 36 months compared with an educational control.

Results: We randomized 138 individuals to the intervention group and 143 to control. At baseline, mean (SD) eGFR was 80.7 (21.7) mL/min/1.73m 2 , 56% of participants had chronic kidney disease and a history of uncontrolled hypertension with a baseline SBP of 134.3 mm Hg. The mean (SD) decline in eGFR by cystatin C from baseline to 36 months was 5.0 (19.6) and 5.9 (18.6) mL/min/1.73m 2 for the control and intervention groups, respectively, with no significant between-group difference ( P =0.75).

Conclusions: We did not observe a significant difference in clinical outcomes by study arm. However, we showed that individuals with DKD will engage in a pharmacist-led intervention. The potential explanations for a lack of change in DKD risk factors can be attributed to 5 broad issues, challenges: (1) associated with enrolling patients with low eGFR and poor BP control; (2) implementing the intervention; (3) limited duration during which to observe any clinical benefit from the intervention; (4) potential co-intervention or contamination; and (5) low statistical power.

背景/目的:减缓糖尿病肾病(DKD)的进展至关重要。我们开展了一项随机对照试验,针对导致糖尿病肾病恶化的风险因素进行干预:与教育对照组相比,我们评估了以药剂师为主导的干预措施在 36 个月内对估计肾小球滤过率(eGFR)下降的影响,干预措施侧重于支持健康行为、药物管理和自我监测:我们将 138 人随机分配到干预组,将 143 人随机分配到对照组。基线时,eGFR 的平均值(标清)为 80.7 (21.7) mL/min/1.73m2 ,56% 的参与者患有慢性肾脏疾病和未控制的高血压病史,基线 SBP 为 134.3 mm Hg。对照组和干预组的胱抑素 C eGFR 从基线到 36 个月的平均(标度)降幅分别为 5.0 (19.6) 和 5.9 (18.6) mL/min/1.73m2 ,组间差异不显著(P=0.75):我们没有观察到不同研究组的临床结果有明显差异。结论:我们没有观察到不同研究组的临床结果有明显差异,但我们表明,患有 DKD 的人会参与药剂师指导的干预。DKD 风险因素未发生变化的潜在原因可归结为以下 5 大问题和挑战:(1)与招募 eGFR 低和血压控制不佳的患者有关;(2)干预措施的实施;(3)观察干预措施临床获益的时间有限;(4)潜在的共同干预或污染;以及(5)统计能力较低。
{"title":"Clinical Outcomes Among High-Risk Primary Care Patients With Diabetic Kidney Disease: Methodological Challenges and Results From the STOP-DKD Study.","authors":"Hayden B Bosworth, Uptal D Patel, Allison A Lewinski, Clemontina A Davenport, Jane Pendergast, Megan Oakes, Matthew J Crowley, Leah L Zullig, Sejal Patel, Jivan Moaddeb, Julie Miller, Shauna Malone, Huiman Barnhart, Clarissa J Diamantidis","doi":"10.1097/MLR.0000000000002043","DOIUrl":"10.1097/MLR.0000000000002043","url":null,"abstract":"<p><strong>Background/objective: </strong>Slowing the progression of diabetic kidney disease (DKD) is critical. We conducted a randomized controlled trial to target risk factors for DKD progression.</p><p><strong>Methods: </strong>We evaluated the effect of a pharmacist-led intervention focused on supporting healthy behaviors, medication management, and self-monitoring on decline in estimated glomerular filtration rate (eGFR) for 36 months compared with an educational control.</p><p><strong>Results: </strong>We randomized 138 individuals to the intervention group and 143 to control. At baseline, mean (SD) eGFR was 80.7 (21.7) mL/min/1.73m 2 , 56% of participants had chronic kidney disease and a history of uncontrolled hypertension with a baseline SBP of 134.3 mm Hg. The mean (SD) decline in eGFR by cystatin C from baseline to 36 months was 5.0 (19.6) and 5.9 (18.6) mL/min/1.73m 2 for the control and intervention groups, respectively, with no significant between-group difference ( P =0.75).</p><p><strong>Conclusions: </strong>We did not observe a significant difference in clinical outcomes by study arm. However, we showed that individuals with DKD will engage in a pharmacist-led intervention. The potential explanations for a lack of change in DKD risk factors can be attributed to 5 broad issues, challenges: (1) associated with enrolling patients with low eGFR and poor BP control; (2) implementing the intervention; (3) limited duration during which to observe any clinical benefit from the intervention; (4) potential co-intervention or contamination; and (5) low statistical power.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141748542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trajectories and Transitions in Service Use Among Older Veterans at High Risk of Long-Term Institutional Care. 有长期住院治疗高风险的老年退伍军人使用服务的轨迹和过渡。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-08-12 DOI: 10.1097/MLR.0000000000002051
Erin D Bouldin, Ben J Brintz, Jared Hansen, Rand Rupper, Rachel Brenner, Orna Intrator, Bruce Kinosian, Mikayla Viny, Stuti Dang, Mary Jo Pugh

Background: We aimed to identify combinations of long-term services and supports (LTSS) Veterans use, describe transitions between groups, and identify factors influencing transition.

Methods: We explored LTSS across a continuum from home to institutional care. Analyses included 104,837 Veterans Health Administration (VHA) patients 66 years and older at high-risk of long-term institutional care (LTIC). We conduct latent class and latent transition analyses using VHA and Medicare data from fiscal years 2014 to 2017. We used logistic regression to identify variables associated with transition.

Results: We identified 5 latent classes: (1) No Services (11% of sample in 2015); (2) Medicare Services (31%), characterized by using LTSS only in Medicare; (3) VHA-Medicare Care Continuum (19%), including LTSS use in various settings across VHA and Medicare; (4) Personal Care Services (21%), characterized by high probabilities of using VHA homemaker/home health aide or self-directed care; and (5) Home-Centered Interdisciplinary Care (18%), characterized by a high probability of using home-based primary care. Veterans frequently stayed in the same class over the three years (30% to 46% in each class). Having a hip fracture, self-care impairment, or severe ambulatory limitation increased the odds of leaving No Services, and incontinence and dementia increased the odds of entering VHA-Medicare Care Continuum. Results were similar when restricted to Veterans who survived during all 3 years of the study period.

Conclusions: Veterans at high risk of LTIC use a combination of services from across the care continuum and a mix of VHA and Medicare services. Service patterns are relatively stable for 3 years.

背景:我们旨在确定退伍军人使用的长期服务和支持(LTSS)的组合,描述不同群体之间的过渡,并确定影响过渡的因素:我们研究了从家庭护理到机构护理的长期服务和支持。分析对象包括 104,837 名退伍军人健康管理局(VHA)66 岁及以上的长期机构护理(LTIC)高风险患者。我们使用退伍军人健康管理局和医疗保险 2014 至 2017 财年的数据进行了潜类和潜转分析。我们使用逻辑回归来确定与过渡相关的变量:我们确定了 5 个潜在类别:(1) 无服务(2015 年占样本的 11%);(2) 医疗保险服务(31%),特点是仅在医疗保险中使用 LTSS;(3) VHA-Medicare Care Continuum(19%),包括在 VHA 和医疗保险的各种环境中使用 LTSS;(4) 个人护理服务(21%),特点是使用 VHA 家政服务员/家庭健康助理或自主护理的概率较高;(5) 以家庭为中心的跨学科护理(18%),特点是使用家庭基础护理的概率较高。退伍军人在三年中经常保持在同一个级别(每个级别占 30% 至 46% )。髋部骨折、自理能力受损或严重行动不便会增加离开 "无服务 "类别的几率,而大小便失禁和痴呆症会增加进入 "退伍军人医疗保健-医疗保健连续护理 "类别的几率。如果仅限于在研究期间所有三年中都存活下来的退伍军人,结果也类似:结论:LTIC 高风险退伍军人综合使用各种护理服务,并混合使用退伍军人医疗管理局和医疗保险服务。服务模式在 3 年内相对稳定。
{"title":"Trajectories and Transitions in Service Use Among Older Veterans at High Risk of Long-Term Institutional Care.","authors":"Erin D Bouldin, Ben J Brintz, Jared Hansen, Rand Rupper, Rachel Brenner, Orna Intrator, Bruce Kinosian, Mikayla Viny, Stuti Dang, Mary Jo Pugh","doi":"10.1097/MLR.0000000000002051","DOIUrl":"10.1097/MLR.0000000000002051","url":null,"abstract":"<p><strong>Background: </strong>We aimed to identify combinations of long-term services and supports (LTSS) Veterans use, describe transitions between groups, and identify factors influencing transition.</p><p><strong>Methods: </strong>We explored LTSS across a continuum from home to institutional care. Analyses included 104,837 Veterans Health Administration (VHA) patients 66 years and older at high-risk of long-term institutional care (LTIC). We conduct latent class and latent transition analyses using VHA and Medicare data from fiscal years 2014 to 2017. We used logistic regression to identify variables associated with transition.</p><p><strong>Results: </strong>We identified 5 latent classes: (1) No Services (11% of sample in 2015); (2) Medicare Services (31%), characterized by using LTSS only in Medicare; (3) VHA-Medicare Care Continuum (19%), including LTSS use in various settings across VHA and Medicare; (4) Personal Care Services (21%), characterized by high probabilities of using VHA homemaker/home health aide or self-directed care; and (5) Home-Centered Interdisciplinary Care (18%), characterized by a high probability of using home-based primary care. Veterans frequently stayed in the same class over the three years (30% to 46% in each class). Having a hip fracture, self-care impairment, or severe ambulatory limitation increased the odds of leaving No Services, and incontinence and dementia increased the odds of entering VHA-Medicare Care Continuum. Results were similar when restricted to Veterans who survived during all 3 years of the study period.</p><p><strong>Conclusions: </strong>Veterans at high risk of LTIC use a combination of services from across the care continuum and a mix of VHA and Medicare services. Service patterns are relatively stable for 3 years.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Social Risk Screening on Discharge Care Processes and Postdischarge Outcomes: A Pragmatic Mixed-Methods Clinical Trial During the COVID-19 Pandemic. 社会风险筛查对出院护理流程和出院后结果的影响:在 COVID-19 大流行期间进行的务实混合方法临床试验。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-09-06 DOI: 10.1097/MLR.0000000000002048
Andrea S Wallace, Alycia A Bristol, Erin Phinney Johnson, Catherine E Elmore, Sonja E Raaum, Angela Presson, Kaleb Eppich, Mackenzie Elliott, Sumin Park, Benjamin S Brooke, Sumin Park, Marianne E Weiss

Background: Social risk screening during inpatient care is required in new CMS regulations, yet its impact on inpatient care and patient outcomes is unknown.

Objectives: To evaluate whether implementing a social risk screening protocol improves discharge processes, patient-reported outcomes, and 30-day service use.

Research design: Pragmatic mixed-methods clinical trial.

Subjects: Overall, 4130 patient discharges (2383 preimplementation and 1747 postimplementation) from general medicine and surgical services at a 528-bed academic medical center in the Intermountain United States and 15 attending physicians.

Measures: Documented family interaction, late discharge, patient-reported readiness for hospital discharge and postdischarge coping difficulties, readmission and emergency department visits within 30 days postdischarge, and coded interviews with inpatient physicians.

Results: A multivariable segmented regression model indicated a 19% decrease per month in odds of family interaction following intervention implementation (OR=0.81, 95% CI=0.76-0.86, P<0.001), and an additional model found a 32% decrease in odds of being discharged after 2 pm (OR=0.68, 95% CI=0.53-0.87, P=0.003). There were no postimplementation changes in patient-reported discharge readiness, postdischarge coping difficulties, or 30-day hospital readmissions, or ED visits. Physicians expressed concerns about the appropriateness, acceptability, and feasibility of the structured social risk assessment.

Conclusions: Conducted in the immediate post-COVID timeframe, reduction in family interaction, earlier discharge, and provider concerns with structured social risk assessments likely contributed to the lack of intervention impact on patient outcomes. To be effective, social risk screening will require patient/family and care team codesign its structure and processes, and allocation of resources to assist in addressing identified social risk needs.

背景:CMS 新规定要求在住院治疗期间进行社会风险筛查,但其对住院治疗和患者预后的影响尚不清楚:CMS 新法规要求在住院治疗期间进行社会风险筛查,但其对住院治疗和患者预后的影响尚不清楚:评估社会风险筛查方案的实施是否能改善出院流程、患者报告的结果以及 30 天的服务使用情况:研究设计:务实的混合方法临床试验:美国山间地区一家拥有 528 张病床的学术医疗中心的普通内科和外科服务机构的 4130 名出院患者(实施前 2383 名,实施后 1747 名)和 15 名主治医生:测量指标:有记录的家庭互动、延迟出院、患者报告的出院准备情况和出院后的应对困难、出院后 30 天内的再入院和急诊就诊情况,以及对住院医生的编码访谈:多变量分段回归模型显示,干预措施实施后,家庭互动的几率每月降低了19%(OR=0.81,95% CI=0.76-0.86,PC结论):COVID刚结束时,家庭互动的减少、出院时间的提前以及医疗服务提供者对结构化社会风险评估的担忧可能是导致干预对患者预后缺乏影响的原因。社会风险筛查要想取得成效,需要患者/家属和护理团队共同设计其结构和流程,并分配资源以协助解决已识别的社会风险需求。
{"title":"Impact of Social Risk Screening on Discharge Care Processes and Postdischarge Outcomes: A Pragmatic Mixed-Methods Clinical Trial During the COVID-19 Pandemic.","authors":"Andrea S Wallace, Alycia A Bristol, Erin Phinney Johnson, Catherine E Elmore, Sonja E Raaum, Angela Presson, Kaleb Eppich, Mackenzie Elliott, Sumin Park, Benjamin S Brooke, Sumin Park, Marianne E Weiss","doi":"10.1097/MLR.0000000000002048","DOIUrl":"10.1097/MLR.0000000000002048","url":null,"abstract":"<p><strong>Background: </strong>Social risk screening during inpatient care is required in new CMS regulations, yet its impact on inpatient care and patient outcomes is unknown.</p><p><strong>Objectives: </strong>To evaluate whether implementing a social risk screening protocol improves discharge processes, patient-reported outcomes, and 30-day service use.</p><p><strong>Research design: </strong>Pragmatic mixed-methods clinical trial.</p><p><strong>Subjects: </strong>Overall, 4130 patient discharges (2383 preimplementation and 1747 postimplementation) from general medicine and surgical services at a 528-bed academic medical center in the Intermountain United States and 15 attending physicians.</p><p><strong>Measures: </strong>Documented family interaction, late discharge, patient-reported readiness for hospital discharge and postdischarge coping difficulties, readmission and emergency department visits within 30 days postdischarge, and coded interviews with inpatient physicians.</p><p><strong>Results: </strong>A multivariable segmented regression model indicated a 19% decrease per month in odds of family interaction following intervention implementation (OR=0.81, 95% CI=0.76-0.86, P<0.001), and an additional model found a 32% decrease in odds of being discharged after 2 pm (OR=0.68, 95% CI=0.53-0.87, P=0.003). There were no postimplementation changes in patient-reported discharge readiness, postdischarge coping difficulties, or 30-day hospital readmissions, or ED visits. Physicians expressed concerns about the appropriateness, acceptability, and feasibility of the structured social risk assessment.</p><p><strong>Conclusions: </strong>Conducted in the immediate post-COVID timeframe, reduction in family interaction, earlier discharge, and provider concerns with structured social risk assessments likely contributed to the lack of intervention impact on patient outcomes. To be effective, social risk screening will require patient/family and care team codesign its structure and processes, and allocation of resources to assist in addressing identified social risk needs.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conduct of Large, Multisite, Comparative Clinical Effectiveness Research Studies: Learnings From the Patient-Centered Outcomes Research Institute's Palliative Care Learning Network. 开展大型、多地点、比较临床疗效研究:以患者为中心的结果研究所姑息治疗学习网络的经验总结》(Patient-Centered Outcomes Research Institute's Palliative Care Learning Network)。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-09-06 DOI: 10.1097/MLR.0000000000002031
Carly L Paterson, Shannon Reefer, Shreeya Khatiwada, Joanna G Philips, Brendaly Rodríguez, Steven B Clauser, Neeraj K Arora
{"title":"Conduct of Large, Multisite, Comparative Clinical Effectiveness Research Studies: Learnings From the Patient-Centered Outcomes Research Institute's Palliative Care Learning Network.","authors":"Carly L Paterson, Shannon Reefer, Shreeya Khatiwada, Joanna G Philips, Brendaly Rodríguez, Steven B Clauser, Neeraj K Arora","doi":"10.1097/MLR.0000000000002031","DOIUrl":"https://doi.org/10.1097/MLR.0000000000002031","url":null,"abstract":"","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing Patient-Centered Outcomes Research Institute Stakeholder Engagement Principles in Models of Palliative Care Delivery and Advance Care Planning Research. 在姑息关怀服务模式和预先关怀规划研究中实施以患者为中心的结果研究所利益相关者参与原则。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-09-06 DOI: 10.1097/MLR.0000000000002025
Anne M Walling, Manisha Verma, Corita R Grudzen, Susan Enguidanos, Nadine J Barrett, Kimberly S Johnson, Angela K Combe, Fabian M Johnston, Joseph A Greer

Background: Given the many challenges of conducting research that addresses the palliative and end-of-life care needs of patients with serious illnesses, stakeholder engagement starting from the moment of study conceptualization and design is critical to ensure successful participant recruitment, data collection, intervention delivery, data analysis, and dissemination.

Methods: Guided by a conceptual model published by the Patient-Centered Outcomes Research Institute (PCORI) entitled, "Measuring What Matters for Advancing the Science and Practice of Engagement"14 and with the support of a PCORI Engagement Officer, representatives from 9 PCORI-funded study teams formed a working group to survey team members and review, outline, and describe key lessons learned and best practices for promoting stakeholder engagement in palliative care research.

Results: Almost all study teams engaged with patients/caregivers, clinicians, researchers, and health care system experts as stakeholder partners. About half the teams also included payers and training institutions as part of their stakeholder advisors as well as a range of content experts. Study teams relied on a variety of support structures and resources, and they employed 10 distinct methods for maintaining engagement. All engagement methods were generally considered to be effective by teams who used the method, though there was some variability in team-rated engagement quality of each method. Nine barriers to stakeholder engagement were identified across the 9 studies as well as 9 strategies (or facilitators) to overcome these barriers. We share examples of how stakeholder engagement impacted studies in all phases, including the preparatory phase, study initiation phase, execution phase, and data analysis/dissemination phase.

Conclusions: Teams utilized a variety of resources and support structures as well as capitalized on multiple engagement methods for fostering stakeholder engagement, resulting in a high level of collaboration and integration.

背景:鉴于开展针对重病患者姑息治疗和临终关怀需求的研究面临诸多挑战,利益相关者从研究构思和设计之初就开始参与,对于确保成功招募参与者、收集数据、提供干预措施、分析数据和传播至关重要:在以患者为中心的结果研究所(PCORI)发布的概念模型 "衡量促进参与的科学与实践的重要因素 "14 的指导下,并在 PCORI 参与官的支持下,来自 9 个 PCORI 资助研究团队的代表组成了一个工作组,对团队成员进行调查,并回顾、概述和描述在姑息关怀研究中促进利益相关者参与的主要经验和最佳实践:几乎所有的研究团队都将患者/护理者、临床医生、研究人员和医疗保健系统专家作为利益相关者的合作伙伴。约有一半的研究团队还将付款人和培训机构以及一系列内容专家作为利益相关者顾问的一部分。研究团队依靠各种支持结构和资源,并采用了 10 种不同的方法来保持参与度。使用过这些方法的团队普遍认为所有参与方法都是有效的,尽管团队对每种方法的参与质量评价存在一定差异。在这 9 项研究中,我们发现了利益相关者参与的 9 个障碍,以及克服这些障碍的 9 个策略(或促进因素)。我们分享了利益相关者参与如何影响各阶段研究的实例,包括准备阶段、研究启动阶段、执行阶段和数据分析/发布阶段:各团队利用各种资源和支持结构,并采用多种参与方法促进利益相关者的参与,从而实现了高度的合作与整合。
{"title":"Implementing Patient-Centered Outcomes Research Institute Stakeholder Engagement Principles in Models of Palliative Care Delivery and Advance Care Planning Research.","authors":"Anne M Walling, Manisha Verma, Corita R Grudzen, Susan Enguidanos, Nadine J Barrett, Kimberly S Johnson, Angela K Combe, Fabian M Johnston, Joseph A Greer","doi":"10.1097/MLR.0000000000002025","DOIUrl":"10.1097/MLR.0000000000002025","url":null,"abstract":"<p><strong>Background: </strong>Given the many challenges of conducting research that addresses the palliative and end-of-life care needs of patients with serious illnesses, stakeholder engagement starting from the moment of study conceptualization and design is critical to ensure successful participant recruitment, data collection, intervention delivery, data analysis, and dissemination.</p><p><strong>Methods: </strong>Guided by a conceptual model published by the Patient-Centered Outcomes Research Institute (PCORI) entitled, \"Measuring What Matters for Advancing the Science and Practice of Engagement\"14 and with the support of a PCORI Engagement Officer, representatives from 9 PCORI-funded study teams formed a working group to survey team members and review, outline, and describe key lessons learned and best practices for promoting stakeholder engagement in palliative care research.</p><p><strong>Results: </strong>Almost all study teams engaged with patients/caregivers, clinicians, researchers, and health care system experts as stakeholder partners. About half the teams also included payers and training institutions as part of their stakeholder advisors as well as a range of content experts. Study teams relied on a variety of support structures and resources, and they employed 10 distinct methods for maintaining engagement. All engagement methods were generally considered to be effective by teams who used the method, though there was some variability in team-rated engagement quality of each method. Nine barriers to stakeholder engagement were identified across the 9 studies as well as 9 strategies (or facilitators) to overcome these barriers. We share examples of how stakeholder engagement impacted studies in all phases, including the preparatory phase, study initiation phase, execution phase, and data analysis/dissemination phase.</p><p><strong>Conclusions: </strong>Teams utilized a variety of resources and support structures as well as capitalized on multiple engagement methods for fostering stakeholder engagement, resulting in a high level of collaboration and integration.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373890/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Children and Youth Are a Critical Part of the American Story of Homelessness. 儿童和青少年是美国无家可归问题的重要组成部分。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-08-07 DOI: 10.1097/MLR.0000000000002052
Gregory D Stevens
{"title":"Children and Youth Are a Critical Part of the American Story of Homelessness.","authors":"Gregory D Stevens","doi":"10.1097/MLR.0000000000002052","DOIUrl":"10.1097/MLR.0000000000002052","url":null,"abstract":"","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Homelessness With Primary Care and Acute Care Utilization Among Medicaid-Enrolled Youth. 无家可归与参加医疗补助计划的青少年使用初级保健和急症护理的关系。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-05-20 DOI: 10.1097/MLR.0000000000002009
Dahai Yue, Emmeline Chuang, Weihao Zhou, Elsie A Essien, Youngeun Lee, Brenna O'Masta, Nadereh Pourat

Background: Youth comprise one-third of the US homeless population. However, little is known about how homelessness affects health care utilization.

Objective: Examine associations of homelessness with hospitalization, primary care, and ED visits, varying by race/ethnicity, among Medicaid-enrolled youth.

Research design: A cross-sectional analysis was conducted using California Medicaid claims data on youth beneficiaries with complex needs. We examined the number of hospitalizations, preventable and nonpreventable ED, and primary care visits using a multivariate regression. We further explored the differential associations by race/ethnicity.

Results: Approximately 17% of our sampled youth experienced homelessness in 2018 (N=90,202). Compared with their housed counterparts, youth experiencing homelessness had a 1.9 percentage point (pp) higher likelihood of frequent ED visits (95% CI: 1.7-2.2) but a 2.9 pp lower probability of any primary care visits (95% CI: -3.9 to -1.9). Homelessness was associated with 221 more ED visits (95% CI: 182-260), 100 more preventable ED visits (95% CI: 84-116), 19.9 more hospitalizations (95% CI: 12-27), but 56 fewer primary care visits (95% CI: -104 to -7), per 1000 youth. The associations of homelessness with total ED visits, preventable ED visits, and needed and nonpreventable ED visits were all higher among Whites and, particularly, Blacks than for Hispanics and Asians.

Conclusions: Medicaid-enrolled youth who experienced homelessness had more overall ED, preventable ED, and hospital visits, but fewer primary care visits than their housed peers. Our results suggest promoting primary care use should be considered among strategies to improve health and reduce costs.

背景:青少年占美国无家可归人口的三分之一。然而,人们对无家可归如何影响医疗服务的使用却知之甚少:研究设计:研究设计:我们使用加州医疗补助计划的报销数据对有复杂需求的青少年受益人进行了横截面分析。我们使用多元回归法研究了住院次数、可预防和不可预防的急诊就诊次数以及初级保健就诊次数。我们进一步探讨了不同种族/族裔之间的关联:2018 年,约有 17% 的抽样青年经历过无家可归(N=90,202)。与有住房的同龄人相比,无家可归的青少年经常去急诊室就诊的可能性高出 1.9 个百分点(95% CI:1.7-2.2),但去初级保健机构就诊的可能性低 2.9 个百分点(95% CI:-3.9 至-1.9)。每 1000 名青少年中,无家可归者导致急诊室就诊次数增加 221 次(95% CI:182-260 次),可预防的急诊室就诊次数增加 100 次(95% CI:84-116 次),住院次数增加 19.9 次(95% CI:12-27 次),但初级保健就诊次数减少 56 次(95% CI:-104--7 次)。无家可归与急诊室就诊总人次、可预防的急诊室就诊人次、所需和不可预防的急诊室就诊人次之间的关系在白人尤其是黑人中均高于西班牙裔和亚裔:参加医疗补助计划的无家可归青少年在急诊室、可预防的急诊室和医院就诊的总人次较多,但初级保健就诊人次少于有住房的同龄人。我们的研究结果表明,在改善健康状况和降低成本的策略中,应考虑促进初级保健的使用。
{"title":"Associations of Homelessness With Primary Care and Acute Care Utilization Among Medicaid-Enrolled Youth.","authors":"Dahai Yue, Emmeline Chuang, Weihao Zhou, Elsie A Essien, Youngeun Lee, Brenna O'Masta, Nadereh Pourat","doi":"10.1097/MLR.0000000000002009","DOIUrl":"10.1097/MLR.0000000000002009","url":null,"abstract":"<p><strong>Background: </strong>Youth comprise one-third of the US homeless population. However, little is known about how homelessness affects health care utilization.</p><p><strong>Objective: </strong>Examine associations of homelessness with hospitalization, primary care, and ED visits, varying by race/ethnicity, among Medicaid-enrolled youth.</p><p><strong>Research design: </strong>A cross-sectional analysis was conducted using California Medicaid claims data on youth beneficiaries with complex needs. We examined the number of hospitalizations, preventable and nonpreventable ED, and primary care visits using a multivariate regression. We further explored the differential associations by race/ethnicity.</p><p><strong>Results: </strong>Approximately 17% of our sampled youth experienced homelessness in 2018 (N=90,202). Compared with their housed counterparts, youth experiencing homelessness had a 1.9 percentage point (pp) higher likelihood of frequent ED visits (95% CI: 1.7-2.2) but a 2.9 pp lower probability of any primary care visits (95% CI: -3.9 to -1.9). Homelessness was associated with 221 more ED visits (95% CI: 182-260), 100 more preventable ED visits (95% CI: 84-116), 19.9 more hospitalizations (95% CI: 12-27), but 56 fewer primary care visits (95% CI: -104 to -7), per 1000 youth. The associations of homelessness with total ED visits, preventable ED visits, and needed and nonpreventable ED visits were all higher among Whites and, particularly, Blacks than for Hispanics and Asians.</p><p><strong>Conclusions: </strong>Medicaid-enrolled youth who experienced homelessness had more overall ED, preventable ED, and hospital visits, but fewer primary care visits than their housed peers. Our results suggest promoting primary care use should be considered among strategies to improve health and reduce costs.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141075709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conducting Comparative Effectiveness, Multisite Palliative Care and Advance Care Planning Trials: Lessons Learned and Future Directions From PCORI-Funded Studies. 开展比较效益、多地点姑息关怀和预先护理规划试验:从 PCORI 资助的研究中汲取的经验和未来方向。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-09-06 DOI: 10.1097/MLR.0000000000002042
Areej El-Jawahri, Brittany Waterman, Susan Enguidanos, Lisa Gibbs, Victor Navarro, Maren Olsen, Jennifer Temel, Annette Totten, Corita R Grudzen

The Patient-Centered Outcomes Research Institute (PCORI) funded multiple large-scale comparative effectiveness clinical trials evaluating palliative care (PC) and advance care planning (ACP) healthcare delivery models. This article provides an overview of the most common barriers our investigative teams encountered while implementing these trials and the strategies we utilized to overcome these challenges, with particular attention to identifying research partners for multisite trials; addressing contracting and regulatory issues; creating a team governance structure; training and engaging study staff across sites; recruiting, consenting, and enrolling study participants; collecting PC and ACP data and study outcomes; and managing multisite collaborations. The goal of this article is to provide guidance on how to best plan for and conduct rigorous trials evaluating PC and ACP healthcare delivery interventions moving forward.

以患者为中心的结果研究所(PCORI)资助了多项大规模比较效果临床试验,对姑息关怀(PC)和预先关怀计划(ACP)医疗服务模式进行评估。本文概述了我们的研究团队在实施这些试验时遇到的最常见障碍,以及我们为克服这些挑战而采取的策略,其中特别关注为多站点试验确定研究合作伙伴;解决合同和监管问题;创建团队治理结构;培训和吸引各站点的研究人员;招募、同意和注册研究参与者;收集 PC 和 ACP 数据及研究结果;以及管理多站点合作。本文旨在就如何更好地规划和开展评估 PC 和 ACP 医疗服务干预措施的严格试验提供指导。
{"title":"Conducting Comparative Effectiveness, Multisite Palliative Care and Advance Care Planning Trials: Lessons Learned and Future Directions From PCORI-Funded Studies.","authors":"Areej El-Jawahri, Brittany Waterman, Susan Enguidanos, Lisa Gibbs, Victor Navarro, Maren Olsen, Jennifer Temel, Annette Totten, Corita R Grudzen","doi":"10.1097/MLR.0000000000002042","DOIUrl":"10.1097/MLR.0000000000002042","url":null,"abstract":"<p><p>The Patient-Centered Outcomes Research Institute (PCORI) funded multiple large-scale comparative effectiveness clinical trials evaluating palliative care (PC) and advance care planning (ACP) healthcare delivery models. This article provides an overview of the most common barriers our investigative teams encountered while implementing these trials and the strategies we utilized to overcome these challenges, with particular attention to identifying research partners for multisite trials; addressing contracting and regulatory issues; creating a team governance structure; training and engaging study staff across sites; recruiting, consenting, and enrolling study participants; collecting PC and ACP data and study outcomes; and managing multisite collaborations. The goal of this article is to provide guidance on how to best plan for and conduct rigorous trials evaluating PC and ACP healthcare delivery interventions moving forward.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Palliative Care and Advance Care Planning Intervention Fidelity Monitoring: Methods and Lessons Learned From PCORI-Funded Large-Scale, Pragmatic Clinical Trials. 姑息关怀和预先护理计划干预的忠实性监测:从 PCORI 资助的大规模务实临床试验中汲取的方法和经验。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-01 Epub Date: 2024-09-06 DOI: 10.1097/MLR.0000000000002037
Manisha Verma, Corita R Grudzen, Seiko Izumi, Neil Wenger, Areej El-Jawahri, Deborah Ejem, Rebecca A Aslakson

Over the past decade, the Patient-Centered Outcomes Research Institute (PCORI) funded multiple large-scale, comparative effectiveness clinical trials evaluating palliative care and advance care planning interventions. These are complex multicomponent interventions that need robust but flexible fidelity monitoring. Fidelity is necessary to maintain both internal and external validity within palliative care intervention research and to ultimately evaluate the real-world impact of high-quality interventions. Different trials not only took varying approaches to fidelity monitoring but also uncovered both unique and common challenges and facilitators. This article summarizes 8 of these trials and highlights approaches, adaptations, barriers, and facilitators for intervention fidelity monitoring. Identifying and delivering core elements while simultaneously allowing adaptations of noncore elements is a vital part of fidelity monitoring. Dissemination of such experiences can inform both future palliative care research as well as ongoing implementation of palliative care and advance care planning interventions across diverse clinical practices. Adoption of rigorous intervention fidelity methods is critical to advancing the science and reproducibility of palliative care interventions.

在过去的十年中,以患者为中心的结果研究所(PCORI)资助了多项大规模的比较有效性临床试验,对姑息关怀和预先护理规划干预措施进行评估。这些都是复杂的多成分干预措施,需要强有力但灵活的保真度监测。为了在姑息关怀干预研究中保持内部和外部有效性,并最终评估高质量干预措施在现实世界中的影响,保真度是必不可少的。不同的试验不仅采取了不同的忠实性监控方法,而且还发现了独特和共同的挑战和促进因素。本文总结了其中的 8 项试验,并重点介绍了干预忠实性监控的方法、调整、障碍和促进因素。确定和提供核心要素,同时允许对非核心要素进行调整,是忠实性监控的重要组成部分。这些经验的传播可以为未来的姑息关怀研究以及在不同临床实践中持续实施姑息关怀和预先医疗规划干预提供信息。采用严格的干预忠实性方法对于推进姑息关怀干预的科学性和可重复性至关重要。
{"title":"Palliative Care and Advance Care Planning Intervention Fidelity Monitoring: Methods and Lessons Learned From PCORI-Funded Large-Scale, Pragmatic Clinical Trials.","authors":"Manisha Verma, Corita R Grudzen, Seiko Izumi, Neil Wenger, Areej El-Jawahri, Deborah Ejem, Rebecca A Aslakson","doi":"10.1097/MLR.0000000000002037","DOIUrl":"10.1097/MLR.0000000000002037","url":null,"abstract":"<p><p>Over the past decade, the Patient-Centered Outcomes Research Institute (PCORI) funded multiple large-scale, comparative effectiveness clinical trials evaluating palliative care and advance care planning interventions. These are complex multicomponent interventions that need robust but flexible fidelity monitoring. Fidelity is necessary to maintain both internal and external validity within palliative care intervention research and to ultimately evaluate the real-world impact of high-quality interventions. Different trials not only took varying approaches to fidelity monitoring but also uncovered both unique and common challenges and facilitators. This article summarizes 8 of these trials and highlights approaches, adaptations, barriers, and facilitators for intervention fidelity monitoring. Identifying and delivering core elements while simultaneously allowing adaptations of noncore elements is a vital part of fidelity monitoring. Dissemination of such experiences can inform both future palliative care research as well as ongoing implementation of palliative care and advance care planning interventions across diverse clinical practices. Adoption of rigorous intervention fidelity methods is critical to advancing the science and reproducibility of palliative care interventions.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Common Ownership among Insurers in Medicare Part D. 医疗保险 D 部分保险公司的共同所有权趋势。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-09-01 Epub Date: 2024-06-28 DOI: 10.1097/MLR.0000000000002030
Pinka Chatterji, Chun-Yu Ho, Alyssa Kamara, Jaehak Lee

Background: Recent studies document the rising prevalence of common ownership by institutional investors in specific industries. Those investors offer products, such as mutual and index funds, to trade securities on behalf of others and often own shares of multiple firms in the same industry to diversify portfolios. However, at present, few studies focus on common ownership trends in health care.

Objectives: This paper examines institutional investors' common ownership in the major insurers offering plans in the Medicare Part D stand-alone prescription drug plan (PDP) market between 2013 and 2020.

Research design: Using data from the Securities and Exchange Commission (SEC) database and the Center for Research in Securities Prices, we compute the percentages of outstanding shares of each insurer owned by institutional investors. Data visualization and network analysis are employed to assess the trends in common ownership among major insurers.

Results: We document a high prevalence of and substantial increase in shared institutional investors in the PDP market. From 2013 to 2020, the degree of common ownership increased by 7% on average, and the common ownership network became more connected. Common ownership also varies across the 34 PDP regions depending on their reliance on listed insurers, that are traded in the stock exchange, offering stand-alone PDPs.

Conclusions: High and rising common ownership in the Medicare Part D PDP market raises policy questions about potential effects on plan offerings, premiums, and quality for consumers.

背景:最近的研究表明,机构投资者在特定行业共同持股的现象日益普遍。这些投资者提供共同基金和指数基金等产品,代表他人进行证券交易,并经常持有同一行业中多家公司的股票,以分散投资组合。然而,目前很少有研究关注医疗保健行业的共同所有权趋势:本文研究了 2013 年至 2020 年间机构投资者在医疗保险 D 部分独立处方药计划(PDP)市场中提供计划的主要保险公司中的共同所有权:利用证券交易委员会(SEC)数据库和证券价格研究中心(Center for Research in Securities Prices)的数据,我们计算了机构投资者持有各保险公司流通股的百分比。数据可视化和网络分析被用来评估主要保险公司共同所有权的趋势:我们发现,在 PDP 市场上,机构投资者共同持股的情况非常普遍,而且还在大幅增加。从 2013 年到 2020 年,共同所有权的程度平均增加了 7%,共同所有权网络的联系更加紧密。34 个 PDP 地区的共同所有权也各不相同,这取决于它们对在证券交易所交易的上市保险公司提供独立 PDP 的依赖程度:结论:医疗保险 D 部分 PDP 市场中的共同所有权较高且不断上升,这引发了有关对计划提供、保费和消费者质量的潜在影响的政策问题。
{"title":"Trends in Common Ownership among Insurers in Medicare Part D.","authors":"Pinka Chatterji, Chun-Yu Ho, Alyssa Kamara, Jaehak Lee","doi":"10.1097/MLR.0000000000002030","DOIUrl":"10.1097/MLR.0000000000002030","url":null,"abstract":"<p><strong>Background: </strong>Recent studies document the rising prevalence of common ownership by institutional investors in specific industries. Those investors offer products, such as mutual and index funds, to trade securities on behalf of others and often own shares of multiple firms in the same industry to diversify portfolios. However, at present, few studies focus on common ownership trends in health care.</p><p><strong>Objectives: </strong>This paper examines institutional investors' common ownership in the major insurers offering plans in the Medicare Part D stand-alone prescription drug plan (PDP) market between 2013 and 2020.</p><p><strong>Research design: </strong>Using data from the Securities and Exchange Commission (SEC) database and the Center for Research in Securities Prices, we compute the percentages of outstanding shares of each insurer owned by institutional investors. Data visualization and network analysis are employed to assess the trends in common ownership among major insurers.</p><p><strong>Results: </strong>We document a high prevalence of and substantial increase in shared institutional investors in the PDP market. From 2013 to 2020, the degree of common ownership increased by 7% on average, and the common ownership network became more connected. Common ownership also varies across the 34 PDP regions depending on their reliance on listed insurers, that are traded in the stock exchange, offering stand-alone PDPs.</p><p><strong>Conclusions: </strong>High and rising common ownership in the Medicare Part D PDP market raises policy questions about potential effects on plan offerings, premiums, and quality for consumers.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141580203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1